Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03701204 · ClinicalTrials.gov registry record · NA
Contingency Management for Alcohol Use Disorder
A NA study, sponsored by DynamiCare Health.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT03701204: Completed NA study, sponsored by DynamiCare Health.
NCT03701204 is a NA study that has completed, run by DynamiCare Health. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03701204, a NA study, has completed, sponsored by DynamiCare Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
Randomized pilot study of a device (smartphone app) that poses non-significant risk to participants and is exempt from Investigational Device Exemption regulations \[21 Code of Federal Regulations 812.2(c)
Primary Outcome
The pilot efficacy study will utilize alcohol abstinence at each assessment time point as the primary outcome. This is defined as a negative ethyl glucuronide urine test (witnessed) at the monthly assessment time points and self-report of no alcohol use in the past 30 days.
Interventions
- BEHAVIORAL DynamiCare Rewards
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2018-10-08 |
| Est. Completion | 2019-08-21 |
| Phase | NA |
What the finished NCT03701204 record still lists
NCT03701204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which DynamiCare Rewards is the first listed.
NCT03701204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03701204 about?
NCT03701204 is a clinical study titled "Contingency Management for Alcohol Use Disorder". Randomized pilot study of a device (smartphone app) that poses non-significant risk to participants and is exempt from Investigational Device Exemption regulations \[21 Code of Federal Regulations 812.2(c)
What is the current status of trial NCT03701204?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2018-10-08. Estimated completion is 2019-08-21.
What interventions are being tested in trial NCT03701204?
The interventions under investigation include: DynamiCare Rewards (BEHAVIORAL).
Who is sponsoring clinical trial NCT03701204?
This trial is sponsored by DynamiCare Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03701204's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI